A personalized mRNA cancer vaccine has reduced the risk of relapse or death in melanoma patients by 42 percent in a large study and could be a significant advance in the fight against skin cancer. #KrebsImpfstoff #mRNAtherapie #PersonalisierteMedizin (translated)
www.bild.de
Durchbruch in großer Studie - Krebs-Impfstoff senkt Sterberisiko um 42 Prozent
